PubRank

R Luukkainen

Author PubWeight™ 62.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet 1999 4.98
2 Effect of gold treatment on the progression of erosions in RA patients. Scand J Rheumatol 1977 2.01
3 CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 2005 1.76
4 HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis. Ann Rheum Dis 2004 1.61
5 Prolonged arthritis associated with sindbis-related (Pogosta) virus infection. Rheumatology (Oxford) 2000 1.52
6 Effect of gold on progression of erosions in rheumatoid arthritis. Better results with early treatment. Scand J Rheumatol 1977 1.35
7 Isolation and characterization of a variety of microcystins from seven strains of the cyanobacterial genus Anabaena. Appl Environ Microbiol 1992 1.22
8 Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium. Arthritis Rheum 1996 1.22
9 Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial. Arthritis Rheum 1988 1.18
10 Intestinal flora in early rheumatoid arthritis. Br J Rheumatol 1994 1.16
11 Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis. Arthritis Rheum 1998 1.12
12 Detection of herpesviruses by polymerase chain reaction in lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum 1993 1.10
13 Combination drug therapy retards the development of rheumatoid atlantoaxial subluxations. Arthritis Rheum 2000 1.09
14 Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol 1993 1.08
15 Sindbis viruses and other alphaviruses as cause of human arthritic disease. J Intern Med 2004 1.07
16 The prediction of radiological destruction during the early stage of rheumatoid arthritis. Clin Exp Rheumatol 1985 1.05
17 Does parvovirus B19 have a role in rheumatoid arthritis? Ann Rheum Dis 1994 1.03
18 The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis. Arthritis Rheum 1996 1.02
19 Yersinia enterocolitica activates a T helper type 1-like T cell subset in reactive arthritis. J Immunol 1992 1.02
20 HLA haplotype analysis in Finnish patients with rheumatoid arthritis. Arthritis Rheum 2001 1.01
21 Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial. Ann Rheum Dis 2005 0.97
22 Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis. Ann Rheum Dis 2000 0.97
23 Non-steroidal anti-oestrogens inhibit the differentiation of synovial macrophages into dendritic cells. Rheumatology (Oxford) 2001 0.95
24 Structures of three new homotyrosine-containing microcystins and a new homophenylalanine variant from Anabaena sp. strain 66. Chem Res Toxicol 1992 0.95
25 Persistence of parvovirus B19 in synovial fluid and bone marrow. Ann Rheum Dis 1995 0.94
26 Prognostic value of the type of onset of rheumatoid arthritis. Ann Rheum Dis 1983 0.93
27 Increased expression of signaling lymphocytic activation molecule in patients with rheumatoid arthritis and its role in the regulation of cytokine production in rheumatoid synovium. J Immunol 1997 0.92
28 Somatic serogroups, capsular types, and species of fecal Klebsiella in patients with ankylosing spondylitis. J Clin Microbiol 1999 0.92
29 Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis. Ann Rheum Dis 1995 0.91
30 Differences between female and male patients with familial rheumatoid arthritis. Ann Rheum Dis 2001 0.90
31 Immunogenetic differences between patients with familial and non-familial rheumatoid arthritis. Ann Rheum Dis 2000 0.88
32 Comparison of the analgesic effect of ten nonsteroidal anti-inflammatory drugs. Br J Rheumatol 1984 0.87
33 Work capacity of patients with inflammatory joint diseases. An eight-year follow-up study. Scand J Rheumatol 1987 0.86
34 Interleukin-15 up-regulates the expression of CD154 on synovial fluid T cells. Immunology 2000 0.85
35 Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis. Ann Rheum Dis 2003 0.85
36 Two new L-serine variants of microcystins-LR and -RR from Anabaena sp. strains 202 A1 and 202 A2. Toxicon 1992 0.84
37 Detection of rubella, mumps, and measles virus genomic RNA in cells from synovial fluid and peripheral blood in early rheumatoid arthritis. J Rheumatol 1997 0.84
38 How often is seropositive rheumatoid arthritis an erosive disease? A 17-year followup study. J Rheumatol 1993 0.83
39 Synovial fluid T cells from patients with rheumatoid arthritis are refractory to the T helper type 2 differentiation-inducing effects of interleukin-4. Immunology 1999 0.83
40 Chrysotherapy in rheumatoid arthritis with particular emphasis on the effect of chrysotherapy on radiographical changes and on the optimal time of initiation of therapy. Scand J Rheumatol Suppl 1980 0.83
41 Long-term prognosis of monoarthritis. A follow-up study. Scand J Rheumatol 1983 0.83
42 Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies. Clin Exp Rheumatol 2011 0.82
43 Type I collagen degradation does not diminish with RA disease duration. Ann Rheum Dis 2001 0.81
44 Ligase chain reaction in detection of Chlamydia DNA in synovial fluid cells. Br J Rheumatol 1997 0.81
45 Detection of cytomegalovirus DNA in cells from synovial fluid and peripheral blood of patients with early rheumatoid arthritis. J Rheumatol 1993 0.81
46 The prevalence of antibodies against Sindbis-related (Pogosta) virus in different parts of Finland. Rheumatology (Oxford) 2003 0.80
47 Expression of bcl-2 in rheumatoid arthritis. Br J Rheumatol 1996 0.80
48 Some characteristics of RA patients with and without side effects due to gold treatment. Scand J Rheumatol 1977 0.79
49 Chronic arthritis after Sindbis-related (Pogosta) virus infection. Scand J Rheumatol 2000 0.79
50 HLA frequencies in HLA-B27 negative patients with reactive arthritis. Clin Exp Rheumatol 1996 0.79
51 Prolonged arthritis associated with Sindbis-related (Pogosta) virus infection. Rheumatology (Oxford) 2002 0.78
52 The value of synovial fluid analysis in the assessment of knee joint destruction in arthritis in a three year follow up study. Ann Rheum Dis 1999 0.78
53 No evidence of adenoviral hexon regions in rheumatoid synovial cells and tissue. J Rheumatol 1994 0.78
54 Treatment of rheumatoid arthritis. Br Med J 1978 0.78
55 Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis. Scand J Rheumatol 2009 0.78
56 Antibodies to streptococcal cell wall in psoriatic arthritis and cutaneous psoriasis. Clin Exp Rheumatol 1997 0.77
57 Expression of soluble human signaling lymphocytic activation molecule in vivo. J Allergy Clin Immunol 1999 0.77
58 Biological treatment in rheumatic diseases: results from a longitudinal surveillance: adverse events. Rheumatol Int 2006 0.77
59 Gold treatment at an early stage of rheumatoid arthritis. Rheumatol Rehabil 1978 0.76
60 Association of tumour necrosis factor a, b and c microsatellite polymorphisms with clinical disease activity and induction of remission in early rheumatoid arthritis. Clin Exp Rheumatol 2007 0.76
61 Relationship between clinical synovitis and radiological destruction, in rheumatoid arthritis. Clin Rheumatol 1983 0.76
62 Mononuclear cell response to enterobacteria and Gram-positive cell walls of normal intestinal microbiota in early rheumatoid arthritis and other inflammatory arthritides. Clin Exp Rheumatol 2002 0.76
63 Pathogen antigen- and superantigen-reactive synovial fluid T cells in reactive arthritis. J Infect Dis 1995 0.75
64 How aggressive should initial therapy for rheumatoid arthritis be? The Finnish experience. Rheumatology (Oxford) 2005 0.75
65 Prevalence of Sindbis-related (Pogosta) virus infections in patients with arthritis. Clin Exp Rheumatol 2003 0.75
66 [Towards more individualized parenteral gold therapy]. Duodecim 1994 0.75
67 Gold in rheumatoid arthritis therapy today. Early treatment. Scand J Rheumatol Suppl 1983 0.75
68 HLA B27 antigens in patients with chronic arthralgia. Scand J Rheumatol 1989 0.75
69 [Relief of pain by 9 anti-rheumatism analgesics]. Duodecim 1983 0.75
70 Radiological and magnetic resonance imaging findings of the sacroiliac joints of HLA B27 antigen negative patients with chronic low back pain. Scand J Rheumatol 2005 0.75
71 Relationship between some joint fluid, blood and serum variables and radiological destruction in knee joints in arthritic patients. Scand J Rheumatol 1986 0.75
72 The coexistence of systemic lupus erythematosus and multiple sclerosis in a mother and daughter. Scand J Rheumatol 2001 0.75
73 A six-month follow-up study of a slow-release indomethacin tablet in rheumatic diseases. Clin Rheumatol 1987 0.75
74 Hidden psoriatic arthritis in seronegative oligoarthritis: a 14-year follow-up study. Clin Rheumatol 1989 0.75
75 Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients. A 5-year follow-up study. Arch Neurol 1993 0.75
76 [Systemic scleroderma and rheumatoid arthritis in the same patient]. Duodecim 1988 0.75